CJC-1295 (no DAC) + IPA

CJC-1295 (No DAC) + IPA – Precision Dual-Peptide Blend for Advanced Hormone Research | Orbitrex Peptides

CJC-1295 (no DAC) + IPA is a premium dual-peptide formulation offered by Orbitrex Peptides, designed to support advanced laboratory research into growth hormone signaling, receptor interaction, and endocrine pathway modulation. Combining two well-studied peptides in one formulation, CJC-1295 (no DAC) + IPA provides researchers with a powerful and efficient tool for investigating pulsatile hormone release and cellular response mechanisms.

At Orbitrex Peptides, we focus on delivering high-purity compounds that meet strict scientific standards. Each vial of CJC-1295 (no DAC) + IPA is manufactured under controlled conditions to ensure consistency, stability, and reliable performance in professional research environments.

---

What is CJC-1295 (No DAC) + IPA?

CJC-1295 (no DAC) + IPA is a combination of two peptides: CJC-1295 without Drug Affinity Complex (DAC) and Ipamorelin. These compounds are commonly studied for their role in stimulating growth hormone release through distinct but complementary mechanisms.

CJC-1295 (no DAC) functions as a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin acts as a ghrelin receptor agonist. When combined, CJC-1295 (no DAC) + IPA allows researchers to examine synergistic effects on growth hormone pulsatility without prolonged systemic exposure associated with DAC-modified variants.

This makes CJC-1295 (no DAC) + IPA particularly valuable in studies requiring controlled, short-acting peptide activity and precise timing of hormone release.

---

Purity and Quality Assurance

Orbitrex Peptides ensures that every batch of CJC-1295 (no DAC) + IPA meets the highest research-grade standards through rigorous testing and verification:

• 99%+ purity confirmed through 3rd-Party Certificates of Analysis (COAs)
• Reverse-phase HPLC with UV detection for structural validation
• Endotoxicology testing using kinetic chromogenic LAL assay

These quality assurance protocols guarantee that CJC-1295 (no DAC) + IPA maintains exceptional consistency and reliability for reproducible laboratory results.

---

Product Specifications

Each vial of CJC-1295 (no DAC) + IPA is prepared for optimal laboratory handling and stability:

• Form: Lyophilized powder
• Dosage: 5mg CJC-1295 (no DAC) + 5mg Ipamorelin
• Container: 3ml sterile vial with rubber stopper and aluminum crimp seal
• Packaging: Light-shielding protective box

This standardized presentation ensures that CJC-1295 (no DAC) + IPA remains protected from environmental factors that may compromise peptide integrity.

---

Storage and Stability

To preserve the effectiveness of CJC-1295 (no DAC) + IPA, proper storage is essential:

• Short-term storage: 2–8°C
• Long-term storage: -20°C recommended
• Protection: Keep away from light and moisture
• Shelf life: Up to 36 months under proper storage conditions

Following these guidelines ensures that CJC-1295 (no DAC) + IPA retains its structural stability and research viability.

---

Research Applications of CJC-1295 (No DAC) + IPA

 is widely studied in laboratory environments focused on hormone signaling and metabolic regulation. Common research applications include:

• Growth hormone release and pulsatility studies
• Endocrine system signaling pathways
• Ghrelin receptor interaction research
• Cellular response to peptide stimulation

Because of its dual-action mechanism, allows researchers to explore complex hormonal interactions with greater precision. Its short-acting nature provides flexibility in experimental design, making it ideal for time-sensitive studies.

For additional scientific insights, researchers may refer to:
https://pubchem.ncbi.nlm.nih.gov/

---

Why Choose Orbitrex Peptides?

Orbitrex Peptides is committed to supporting the scientific community with high-quality research compounds. When purchasing, you benefit from:

• Verified 99%+ purity with full COA transparency
• Consistent batch production for reproducible results
• Secure, laboratory-grade packaging
• Same-day shipping for fast order processing
• Group testing promos for research institutions

Our dedication to quality ensures that CJC-1295 (no DAC) + IPA meets the expectations of professional researchers worldwide.

---

Compliance and Safety Notice

 is strictly intended for research use only. It is not approved for human or veterinary consumption and must not be used as a drug, food additive, cosmetic, or household product.

All handling should be conducted by qualified professionals in appropriate laboratory environments.

---

Conclusion

With its synergistic formulation and precise activity profile,  is a valuable compound for advanced endocrine and metabolic research. Orbitrex Peptides ensures that each vial is manufactured and tested to meet the highest standards, providing researchers with a dependable and high-performance peptide solution.

If you are seeking a reliable dual-peptide formulation,  Orbitrex Peptides delivers the purity, consistency, and precision required to support cutting-edge scientific investigations.